IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

GSK PLC GSK shares slipped 2.45% to £15.36 Friday, on what proved to be an all-around grim trading session for the stock ...

Coca-Cola Co. plans to inject $1 billion investment in Nigeria over the next five years, motivated by ongoing reforms ...

Our Fool likes the look of these stock market juggernauts for the chunky passive income they throw off, not to mention their ...

Coca-Cola plans to invest $1 billion in its Nigeria operations over the next five years, the country's presidency said after ...

Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...

Climate Asset Management has raised more than $1 billion to invest in natural capital projects such as regenerative agriculture, its chief executive told Reuters.

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

Charity donations from the UK’s biggest publicly listed companies have not kept pace with their profits over the last 10 ...

Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...